Mericana Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 2019.
2019 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Mericana Pharmaceuticals Private Limited

Mericana Pharmaceuticals Private Limited, a active private limited company, was established on 29 March 2019 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U33110MP2019PTC048220. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Suresh Kshirsagar (Director), Gaurav Kshirsagar (Director), Priyesh Kumar Sinha (Director). Past directors included Gaurav Kshirsagar, Priyesh Kumar Sinha. It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at C/O- Suresh Kshirsagar 556, Usha Nagar Extension, Indore, Madhya Pradesh, 452009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33110MP2019PTC048220

  • Registration Number

    048220

  • Incorporation Date

    29 March 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 1 Month
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 1.00 Cr
  • Revenue Growth **** 14.76%
  • Profit Growth **** 0.17%
  • Ebitda **** 6.06%
  • Net Worth 31.45%
  • Total Assets **** 46.21%
Company report

Mericana Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Mericana Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Mericana Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Suresh Kshirsagar Director 29 Mar 2019 Current
Gaurav Kshirsagar Director 24 Sep 2020 Current
Priyesh Kumar Sinha Director 24 Sep 2020 Current
Madan Kumar Sinha Director 29 Mar 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Dec 2020 Past
Pramod Abcsdd Additional Director 30 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mericana Pharmaceuticals.

Mericana Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.76% increase. The company also saw a slight improvement in profitability, with a 0.17% increase in profit. The company's net worth Soared by an impressive increase of 31.45%.

Mericana Pharmaceuticals revenue growth over time
Mericana Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 14.76%
*******
*******
*******
*******
Revenue from Operations
*******
 16.52%
*******
*******
*******
*******
Total Assets
*******
 46.21%
*******
*******
*******
*******
Profit or Loss
*******
 0.17%
*******
*******
*******
*******
Net Worth
*******
 31.45%
*******
*******
*******
*******
EBITDA
*******
 6.06%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mericana Pharmaceuticals?

In 2023, Mericana Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹10,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 1.00 Cr
Latest Charge Details
Date Lender Amount Status
23 Dec 2024 Hdfc Bank Limited ₹1.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Mericana Pharmaceuticals?

Unlock and access historical data on people associated with Mericana Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mericana Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mericana Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mericana Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 10.00 M with Charge ID 101031429 was registered on 23 Dec 2024. was documented.

  • Annual General Meeting

    Progress on Mericana Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Mericana Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Gwalior. was documented.

  • Director Appointment

    Gaurav Kshirsagar was appointed as a Director was appointed as a Director on 24 Sep 2020 & has been associated with this company since 5 years 8 months . was recorded as a recent event.

  • Director Appointment

    Priyesh Kumar Sinha was appointed as a Director was appointed as a Director on 24 Sep 2020 & has been associated with this company since 5 years 8 months . was recorded as a recent event.

  • Director Appointment

    Progress on Suresh Kshirsagar was appointed as a Director was appointed as a Director on 29 Mar 2019 & has been associated with this company since 7 years 1 month . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mericana Pharmaceuticals Private Limited?

The CIN of Mericana Pharmaceuticals Private Limited is U33110MP2019PTC048220.

Where is Mericana Pharmaceuticals Private Limited headquartered?

Mericana Pharmaceuticals Private Limited is headquartered at C/O- Suresh Kshirsagar 556, Usha Nagar Extension, Indore, Madhya Pradesh, 452009.

When was Mericana Pharmaceuticals Private Limited incorporated?

Mericana Pharmaceuticals Private Limited was incorporated on 29 March 2019.

Who are the current directors of Mericana Pharmaceuticals Private Limited?

The current directors of Mericana Pharmaceuticals Private Limited are

What is the primary industry of Mericana Pharmaceuticals Private Limited?

The primary industry of Mericana Pharmaceuticals Private Limited is Trade.

Is Mericana Pharmaceuticals Private Limited a listed company?

Mericana Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Mericana Pharmaceuticals Private Limited?

The authorized capital of Mericana Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available